Search results
We are an innovation-led contract research, development and manufacturing organization offering integrated scientific services from early discovery to commercial supply. We offer clients a customized end-to-end solution to fulfil their R&D and manufacturing requirements.
Syngene is a contract research, development and manufacturing organization (CRDMO) that provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods and agrochemical companies.
Life at Syngene is a dynamic and empowering experience for our employees. With almost three decades dedicated to supporting the R&D requirements of customers, our success is due to our unwavering commitment to learning and innovation.
Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022) is an integrated research, development, and manufacturing services company serving the global pharmaceutical,...
For three decades, Syngene has been dedicated to exploring the boundaries of science. Our focus is on developing solutions that enhance human and animal health and advancing the creation of next-generation materials.
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated service provider offering end-to-end drug discovery, development, and manufacturing services on a single platform (CRAMS).
Discover Syngene's 2024 Annual Report for insights into our advancements in drug discovery, development, and manufacturing solutions for global pharmaceutical and biotech companies.
We will keep you informed about job opportunities and events that match your interests. Already a member? © 2024. Syngene International Limited.
Syngene International Ltd established in 1994, Syngene was Indias first Custom Research Organization to receive special export status by the Government of India.
Syngene International Limited Stock Price Today, Live NSE Share Price: Get the latest Syngene International Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
